Project Grant HT94252410393
Award Date
8/1/24
Completion Date
7/31/28
Dollars Obligated
$2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Boston, MA 02215, USA
Similar Awards
This federal Project Grant award of $1,539,865.00, issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), is supporting research at the University of Utah to confirm the effectiveness of acupuncture in treating the symptoms of Gulf War Illness. The project, set to run from August 1, 2024 to July 31, 2028, will leverage the university's expertise in biomedical research and healthcare services to advance knowledge in this critical area. The...
The Defense Health Agency awarded a $553,725 Project Grant to the University of California, Berkeley under the Military Medical Research and Development program (CFDA 12.420) to confirm the effectiveness of acupuncture in treating the symptoms of Gulf War Illness. The grant, which runs from August 1, 2024 to July 31, 2028, will enable UC Berkeley to conduct research to determine whether acupuncture provides a viable treatment option for the medical issues affecting veterans of the Gulf War. As a...
This federal Project Grant award of $1,991,326.00, awarded by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research at Beth Israel Deaconess Medical Center, Inc. (Bidmc) aimed at suppressing barrier antimicrobial defenses in the context of trauma. The 3-year grant, with a performance period from September 30, 2024 to September 29, 2027, will enable Bidmc, a prominent academic medical center in...
The federal Project Grant award of $1,715,075.00 was provided by the Defense Health Agency to Beth Israel Deaconess Medical Center, Inc. (Bidmc) under the Military Medical Research and Development (CFDA 12.420) program. The funding supports research on "The Role of TBI Derived DAMPS in Bacterial Pneumonia" over a period from September 30, 2023 to September 29, 2026. As a major academic medical center and teaching hospital, Bidmc has an extensive portfolio of federal grants and...
This federal Project Grant award of $518,700.00 was made by the Defense Health Agency on July 1, 2024 to the Beth Israel Deaconess Medical Center, Inc. (Bidmc) in Boston, MA. The award is part of the Military Medical Research and Development (CFDA 12.420) program, which supports biomedical research initiatives to improve health outcomes for military service members, veterans, and the broader public. The funding will support Bidmc's project titled "EXPLOITING DISRUPTION IN TRANSCRIPTIONAL...
This federal Project Grant award of $602,900.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund a study comparing cognitive behavioral therapy and acupuncture for managing chronic pain, titled "COMPARING COGNITIVE BEHAVIORAL THERAPY AND ACUPUNCTURE FOR MANAGING CHRONIC PAIN (COMBAT-PAIN)". The award was made to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., a...
This Project Grant award of $1,723,552.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at Beth Israel Deaconess Medical Center, Inc. (BIDMC) to target specific long non-coding RNAs (lncRNAs) in novel combined therapies. The goal is to modulate the TSP1-dependent immune microenvironment vulnerabilities in advanced thyroid cancer. The research, spanning from September 1, 2025 to August 31, 2028, aims to...
This $345,800 Project Grant was awarded on May 1, 2024 by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to Beth Israel Deaconess Medical Center, Inc. (Bidmc) in Boston, Massachusetts. The grant supports research on the "Role of Stress Granules in the Pathogenesis and Therapy of Pulmonary Hypertension", with a performance period from May 1, 2024 to April 30, 2026. The Military Medical Research and Development program funds a...
The Beth Israel Deaconess Medical Center, Inc. (doing business as Bidmc) received a $1,735,624 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from July 1, 2021 to June 30, 2025 to develop a strain-programmable bioadhesive patch to accelerate healing of diabetic ulcers. The Military Medical Research and Development program aims to transform military and public health through innovative...
The Beth Israel Deaconess Medical Center, Inc. (Bidmc) in Boston, Massachusetts was awarded a $1,296,751 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on June 1, 2024, will fund a 2-year research project titled "Electrical Impedance Myography via the Myolex mScan as an ALS Biomarker." The goal of the project is to evaluate a novel diagnostic approach using electrical impedance myography...